1,049
Participants
Start Date
March 4, 2014
Primary Completion Date
June 15, 2016
Study Completion Date
June 15, 2016
ranibizumab
All patients will receive ranibizumab 0.5 mg/0.05 ml according to approved label: treatment is given monthly until maximum VA is achieved (i.e. stable VA for three consecutive monthly assessments performed while on ranibizumab treatment). Thereafter according to approved label, patients should be monitored monthly for visual acuity and treatment is to be resumed when monitoring indicates loss of visual acuity due to disease activity. Monthly injections should then be administered until stable visual acuity is reached again for three consecutive monthly assessments (implying a minimum of two injections).
Novartis Investigative Site, Torino
Novartis Investigative Site, Torino
Novartis Investigative Site, Torino
Novartis Investigative Site, Ceva
Novartis Investigative Site, Cuneo
Novartis Investigative Site, Casale Monferrato
Novartis Investigative Site, Alessandria
Novartis Investigative Site, Rapallo
Novartis Investigative Site, Genova
Novartis Investigative Site, Genova
Novartis Investigative Site, Savona
Novartis Investigative Site, Sarzana
Novartis Investigative Site, Legnano
Novartis Investigative Site, Vizzolo Predabissi
Novartis Investigative Site, Rozzano
Novartis Investigative Site, Cinisello Balsamo
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Somma Lombardo
Novartis Investigative Site, Busto Arsizio
Novartis Investigative Site, Varese
Novartis Investigative Site, San Feramo Della Battaglia
Novartis Investigative Site, Como
Novartis Investigative Site, Sondrio
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Desenzano del Garda
Novartis Investigative Site, Brescia
Novartis Investigative Site, Pavia
Novartis Investigative Site, Borgomanero
Novartis Investigative Site, Galliate
Novartis Investigative Site, Piacenza
Novartis Investigative Site, Conegliano
Novartis Investigative Site, Treviso
Novartis Investigative Site, Belluno
Novartis Investigative Site, Udine
Novartis Investigative Site, Pordenone
Novartis Investigative Site, Trieste
Novartis Investigative Site, Camposampiero
Novartis Investigative Site, Monselice
Novartis Investigative Site, Padua
Novartis Investigative Site, Padua
Novartis Investigative Site, Santorso
Novartis Investigative Site, Vicenza
Novartis Investigative Site, Negrar
Novartis Investigative Site, Legnago
Novartis Investigative Site, Verona
Novartis Investigative Site, Bolzano
Novartis Investigative Site, Bologna
Novartis Investigative Site, Correggio
Novartis Investigative Site, Reggio Emilia
Novartis Investigative Site, Parma
Novartis Investigative Site, Cona
Novartis Investigative Site, Forlì
Novartis Investigative Site, Riccione
Novartis Investigative Site, Ancona
Novartis Investigative Site, Teramo
Novartis Investigative Site, Pescara
Novartis Investigative Site, Chieti
Novartis Investigative Site, Putignano
Novartis Investigative Site, Acquaviva delle Fonti
Novartis Investigative Site, Terlizzi
Novartis Investigative Site, San Giovanni Rotondo
Novartis Investigative Site, Foggia
Novartis Investigative Site, Tricase
Novartis Investigative Site, Taranto
Novartis Investigative Site, Pozzuoli
Novartis Investigative Site, Napoli
Novartis Investigative Site, Napoli
Novartis Investigative Site, Napoli
Novartis Investigative Site, Caserta
Novartis Investigative Site, Eboli
Novartis Investigative Site, Salerno
Novartis Investigative Site, Crotone
Novartis Investigative Site, Catanzaro
Novartis Investigative Site, Reggio Calabria
Novartis Investigative Site, Palermo
Novartis Investigative Site, Palermo
Novartis Investigative Site, Acireale
Novartis Investigative Site, Catania
Novartis Investigative Site, Catania
Novartis Investigative Site, Milazzo
Novartis Investigative Site, Messina
Novartis Investigative Site, Cagliari
Novartis Investigative Site, Larino
Novartis Investigative Site, Terracina
Novartis Investigative Site, Nuoro
Novartis Investigative Site, Città di Castello
Novartis Investigative Site, Foligno
Novartis Investigative Site, Perugia
Novartis Investigative Site, Civitavecchia
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Sassari
Novartis Investigative Site, Terni
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY